Hospira Dacarbazine for Injection BP, 200 mg vial

מדינה: אוסטרליה

שפה: אנגלית

מקור: Department of Health (Therapeutic Goods Administration)

מרכיב פעיל:

dacarbazine, Quantity: 200 mg

זמין מ:

Hospira Australia Pty Ltd

INN (שם בינלאומי):

Dacarbazine

טופס פרצבטיות:

Injection, powder for

הרכב:

Excipient Ingredients: citric acid monohydrate; mannitol; sodium hydroxide

מסלול נתינה (של תרופות):

Intravenous

יחידות באריזה:

1 x 20 mL vial

סיווג:

Medicine Listed (Export Only)

סוג מרשם:

Not scheduled. Not considered by committee

סממני תרפויטית:

Dacarbazine is indicated for the treatment of patients with metastatic malignant melanoma. Dacarbazine is used as part of combination chemotherapy for the treatment of advanced Hodgkin's disease, advanced adult soft tissue sarcomas (except mesothelioma and Kaposi sarcoma). Dacarbazine has been shown, when used in combination with other cytotoxic agents, to be of use in the treatment of other malignant diseases including carcinoma of the colon, ovary, breast, lung, testicular teratoma, and solid tumours in children.

leaflet_short:

Visual Identification: A white or very pale yellow powder or plug; Container Type: Vial; Container Life Time: 18 Months

מצב אישור:

Licence status A

תאריך אישור:

2006-02-15